Vimta Labs Ltd-$
Vimta Labs Ltd-$ (VIMTALABS) last reported results for the quarter ended Dec 2024, with sales of ₹90 crore and net profit of ₹22 crore. The stock last traded at ₹581, a market capitalisation of ₹2,595 crore, on a P/E of 42.7. Over the past 52 weeks the stock has ranged between ₹376 and ₹775. Figures are as of 6 Oct 2026 and are not real time.
Vimta Labs Ltd-$ share price and key metrics
- Current price
- ₹581
- Market cap
- ₹2,595 cr
- Stock P/E
- 42.7
- Book value
- ₹77.2
- ROE
- 13.5%
- ROCE
- 17.6%
- Dividend yield
- 0.35%
- 52w high / low
- 775/376
Metrics as of 6 Oct 2026. Not real time.
Track Vimta Labs Ltd-$
Cruxal reads every Vimta Labs Ltd-$ filing as it lands, scores what it means for the stock, and emails you the ones that matter. Free to start.
Vimta Labs Ltd-$ growth and returns
- 10 Years
- %
- 5 Years
- %
- 3 Years
- 15%
- TTM
- 8%
- 10 Years
- %
- 5 Years
- %
- 3 Years
- 24%
- TTM
- 34%
- 10 Years
- 27%
- 5 Years
- 31%
- 3 Years
- 27%
- 1 Year
- -23%
- 10 Years
- %
- 5 Years
- 14%
- 3 Years
- 17%
- Last Year
- 14%
Vimta Labs Ltd-$ quarterly results
In the quarter ended Dec 2024, sales were ₹90 cr, up 20.0% from ₹75 cr a year earlier. Net profit was ₹22 cr, up 120.0% year on year.
| ₹ crore | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|---|---|---|
| Sales | 82 | 83 | 66 | 75 | 80 | 75 | 85 | 90 |
| Expenses | 58 | 59 | 48 | 51 | 55 | 49 | 55 | 57 |
| Operating profit | 24 | 25 | 17 | 24 | 24 | 26 | 30 | 33 |
| OPM % | 30% | 30% | 27% | 32% | 31% | 35% | 35% | 37% |
| Other income | 1 | 1 | 0 | -1 | 0 | -1 | -1 | 5 |
| Interest | 0 | 0 | 1 | 1 | 1 | 0 | 0 | 1 |
| Depreciation | 8 | 8 | 9 | 8 | 8 | 8 | 8 | 10 |
| Profit before tax | 17 | 16 | 8 | 14 | 16 | 17 | 20 | 28 |
| Tax % | 23% | 25% | 25% | 25% | 24% | 26% | 24% | 23% |
| Net profit | 13 | 12 | 6 | 10 | 12 | 12 | 15 | 22 |
| EPS (₹) | 2.86 | 2.75 | 1.43 | 2.29 | 2.79 | 2.77 | 3.44 | 4.84 |
Consolidated figures as reported by the company. Percentages are as published; totals may not sum exactly.
Vimta Labs Ltd-$ annual results
| ₹ crore | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | TTM |
|---|---|---|---|---|---|---|
| Sales | 181 | 211 | 278 | 318 | 318 | 329 |
| Operating profit | 30 | 53 | 80 | 95 | 87 | 113 |
| OPM % | 17% | 25% | 29% | 30% | 27% | 34% |
| Net profit | 7 | 21 | 41 | 48 | 41 | 61 |
| EPS (₹) | 1.55 | 4.84 | 9.35 | 10.87 | 9.26 | 13.84 |
TTM is the trailing twelve months to the most recent quarter.
Vimta Labs Ltd-$ balance sheet
| ₹ crore | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Sep 2024 |
|---|---|---|---|---|---|---|
| Equity capital | 4 | 4 | 4 | 4 | 4 | 4 |
| Reserves | 168 | 190 | 230 | 277 | 315 | 338 |
| Borrowings | 33 | 30 | 19 | 15 | 19 | 12 |
| Other liabilities | 40 | 50 | 54 | 65 | 61 | 86 |
| Total liabilities | 246 | 274 | 307 | 362 | 400 | 440 |
| Fixed assets | 138 | 135 | 169 | 175 | 171 | 183 |
| CWIP | 2 | 17 | 0 | 12 | 59 | 75 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 |
| Other assets | 106 | 122 | 138 | 175 | 170 | 183 |
| Total assets | 246 | 274 | 307 | 362 | 400 | 440 |
As reported by the company. Total assets equal total liabilities by construction.
Vimta Labs Ltd-$ cash flow
| ₹ crore | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 |
|---|---|---|---|---|---|
| Cash from operations | 24 | 37 | 59 | 88 | 61 |
| Cash from investing | -21 | -32 | -38 | -57 | -76 |
| Cash from financing | -1 | -5 | -17 | -11 | -2 |
| Net cash flow | 3 | 1 | 5 | 20 | -17 |
| Free cash flow | 9 | 4 | 20 | 38 | -14 |
| CFO / operating profit | 102% | 84% | 94% | 106% | 88% |
Negative figures are outflows. CFO / operating profit is a ratio, not an amount.
Vimta Labs Ltd-$ operating ratios
| Per year | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 |
|---|---|---|---|---|---|
| ROCE % | — | 14% | 24% | 25% | 18% |
| Debtor days | 117 | 127 | 101 | 92 | 100 |
| Inventory days | 191 | 140 | 115 | 187 | 185 |
| Days payable | 117 | 142 | 82 | 119 | 62 |
| Cash conversion cycle | 191 | 125 | 134 | 159 | 223 |
| Working capital days | 64 | 86 | 86 | 76 | 89 |
Ratios as computed by the source from the reported statements. Rows a company does not report are omitted.
Vimta Labs Ltd-$ shareholding pattern
Promoters held 35.66% at Jun 2026, down from 36.67% at Jun 2025. FIIs 4.41% and DIIs 0.37%.
| % held | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Promoters | 36.89% | 36.76% | 36.70% | 36.67% | 35.99% | 35.89% | 35.85% | 35.66% |
| FIIs | 3.31% | 3.81% | 3.66% | 3.49% | 4.33% | 4.59% | 4.89% | 4.41% |
| DIIs | 0.00% | 1.15% | 1.43% | 1.42% | 0.87% | 0.11% | 0.13% | 0.37% |
| Public | 59.80% | 58.28% | 58.20% | 58.42% | 58.80% | 59.40% | 59.12% | 59.55% |
| No. of shareholders | 20,114 | 21,156 | 26,183 | 30,829 | 55,933 | 54,467 | 51,623 | 50,190 |
As disclosed by the company to the exchanges. The last row is a count of shareholders, not a percentage.
Vimta Labs Ltd-$ corporate filings
- Intimation for closure of Trading Window.Insider Trading / SASTlow impact
- Vimta Labs Ltd announces allotment of shares under Employee Stock Option Plan 2021Company Updatelow impact
Cruxal's analysis: Vimta Labs has executed an allotment of equity shares pursuant to the exercise of options…
Read the full analysis - Vimta Labs Ltd schedules analyst and institutional investor meetingCompany Updatelow impact
Cruxal's analysis: Vimta Labs has issued an intimation regarding a scheduled meeting with analysts and…
Read the full analysis - Vimta Labs Limited maintains 'CARE A; Stable / CARE A1' credit ratings on bank facilitiesCompany Updatelow impact
Cruxal's analysis: Vimta Labs Limited has received a reaffirmation of its 'CARE A; Stable / CARE A1' credit…
Read the full analysis - Vimta Labs clarifies on recent increase in trading volumeCompany Updatelow impact
Cruxal's analysis: Vimta Labs Ltd has issued a formal clarification to the stock exchanges regarding the…
Read the full analysis - Vimta Labs Ltd schedules analyst/institutional investor meetingCompany Updatelow impact
Cruxal's analysis: Vimta Labs has issued an intimation regarding a scheduled meeting with analysts and…
Read the full analysis - Vimta Labs schedules analyst and institutional investor meetingCompany Updatelow impact
Cruxal's analysis: Vimta Labs has issued an intimation regarding a scheduled meeting with analysts and…
Read the full analysis - Vimta Labs reports cyber security incidentCompany Updatemedium impact
Cruxal's analysis: Vimta Labs has issued an intimation regarding a cyber security incident. The company has…
Read the full analysis
This page shows filings on a one-hour delay. Sign in to see them as they land, with Cruxal's analysis of what each one means.
Cruxal publishes market data and coverage for information only. Nothing here is investment advice.